Discover 1,825 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,825
Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP
for
HIV Prevention, HIV Pre-exposure Prophylaxis,
Location: Durham NC
Sponsor: Duke University
Sex: Male
Age: 18+
Code: NCT07218211
Phase 4, Recruiting
Using PrEP, Doing It for Ourselves
for
HIV Prevention, PrEP
Location: Durham NC
Sponsor: Duke University
Sex: Female
Age: 18+
Code: NCT06638892
Recruiting
MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets
for
Brain Metastases, Neurocognitive Deficit,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
for
Cirrhosis, Cirrhosis, Liver, Cirrhosis Early,
Location: Durham NC, Richmond VA, Cleveland OH, New York NY,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 18 - 70+
Code: NCT05832229
Phase 2, Recruiting
Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation
for
Kidney Transplant
Location: Durham NC, Charlottesville VA, Baltimore MD,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70
Code: NCT05917522
Phase 2, Recruiting
Allopregnanolone (Zuranolone) in Post-stroke Depression
for
Post Stroke Depression
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 21 - 65
Code: NCT06759558
Phase 2, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype